This announcement is a separate document:
凯普生物:关于全资子公司获得《药物临床试验批准通知书》的公告
Capbio: Announcement on the wholly-owned subsidiary obtaining the “Drug Clinical Trial Approval Notice”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.